These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 2392924

  • 1. [Prostaglandins, suppressive action cells and carcinoma of the larynx: preliminary data].
    Vitiello R, Giordano C, Macchieraldo A, Pecorari G, Sartoris A.
    Acta Otorhinolaryngol Ital; 1990; 10(1):73-8. PubMed ID: 2392924
    [Abstract] [Full Text] [Related]

  • 2. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
    Licastro F, Lenzi M, Chiricolo M, Davis LJ, Cassani F, Bianchi F, Franceschi C.
    J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
    [Abstract] [Full Text] [Related]

  • 3. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR, Stelzer GT, Eades DS, Cohen R, Wallace JH.
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [Abstract] [Full Text] [Related]

  • 4. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
    Rocklin RE, Thistle L, Audera C.
    J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
    [Abstract] [Full Text] [Related]

  • 5. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA, Jelinek DF, Lipsky PE.
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [Abstract] [Full Text] [Related]

  • 6. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
    Tilden AB, Balch CM.
    Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
    [Abstract] [Full Text] [Related]

  • 7. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI, Lukach EV, Krivokhatskaia LD.
    Eksp Onkol; 1988 Sep; 10(3):54-7. PubMed ID: 2970382
    [Abstract] [Full Text] [Related]

  • 8. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
    Koster FT, Williams JC, Goodwin JS.
    J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy.
    Bahr GM, Rook GA, Stanford JL.
    Clin Exp Immunol; 1981 Sep; 45(3):646-53. PubMed ID: 7039874
    [Abstract] [Full Text] [Related]

  • 10. Immune reactivity and clinical stage of patients with laryngeal cancer.
    Turowski G, Konieczna A, Horeczy M.
    Mater Med Pol; 1991 Sep; 23(3):182-6. PubMed ID: 1842711
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
    Papadogiannakis N, Johnsen SA, Olding LB.
    Clin Exp Immunol; 1985 Jul; 61(1):125-34. PubMed ID: 2931220
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
    Mantovani G, Coiana A, Massidda A, Proto E, Floris C, Macciò A, Pusceddu G, Del Giacco GS.
    Diagn Clin Immunol; 1987 Jul; 5(2):104-11. PubMed ID: 3497733
    [Abstract] [Full Text] [Related]

  • 16. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ, Renoux ML.
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [Abstract] [Full Text] [Related]

  • 17. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP, Harris JE.
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [Abstract] [Full Text] [Related]

  • 18. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI, Bostick-Bruton F.
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [Abstract] [Full Text] [Related]

  • 19. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
    Fischer A, Le Deist F, Durandy A, Griscelli C.
    J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
    [Abstract] [Full Text] [Related]

  • 20. Production of prostaglandin E2 by tumor cells in vitro.
    Owen K, Gomolka D, Droller MJ.
    Cancer Res; 1980 Sep; 40(9):3167-71. PubMed ID: 7427935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.